|
ZNF776 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63546953757532E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.93950419560929E-11 |
| Normal-vs-Stage2 |
1.22110000000397E-07 |
| Normal-vs-Stage3 |
1.4148682225823E-12 |
| Normal-vs-Stage4 |
4.73343586548935E-12 |
| Stage1-vs-Stage2 |
6.168600E-01 |
| Stage1-vs-Stage3 |
2.462200E-02 |
| Stage1-vs-Stage4 |
3.877300E-03 |
| Stage2-vs-Stage3 |
2.798200E-01 |
| Stage2-vs-Stage4 |
4.757800E-02 |
| Stage3-vs-Stage4 |
2.789600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72084568816899E-14 |
| Normal-vs-AfricanAmerican |
1.098180E-03 |
| Normal-vs-Asian |
8.47190000041742E-07 |
| Caucasian-vs-AfricanAmerican |
2.005200E-01 |
| Caucasian-vs-Asian |
3.954000E-01 |
| AfricanAmerican-vs-Asian |
5.906200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.07380035155813E-10 |
| Normal-vs-Female |
1.64057656348859E-12 |
| Male-vs-Female |
3.939200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.05339958977879E-10 |
| Normal-vs-Age(41-60Yrs) |
6.06659167345924E-12 |
| Normal-vs-Age(61-80Yrs) |
1.17940102128955E-11 |
| Normal-vs-Age(81-100Yrs) |
2.819500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.586400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.527800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.921400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.526200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.284800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.968800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.10209999999389E-05 |
| Classical-VS-Follicular |
1.957160E-01 |
| Classical-VS-Other |
6.306400E-01 |
| Classical-VS-Normal |
1.82840409479468E-11 |
| Tall-VS-Follicular |
1.064090E-02 |
| Tall-VS-Other |
3.993400E-01 |
| Tall-VS-Normal |
1.37867495197952E-12 |
| Follicular-VS-Other |
9.667400E-01 |
| Follicular-VS-Normal |
1.91530002968676E-09 |
| Other-VS-Normal |
8.604500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.83479914489726E-11 |
| Normal-vs-N1 |
9.45019995590712E-09 |
| N0-vs-N1 |
5.086600E-01 |
|
|
